17/06/2020 07:31 PM

PUTRAJAYA, June 17 -- The Health Ministry (MOH) today advised the public not to consume or misuse the drug Dexamethasone to treat COVID-19 without a doctor’s prescription. 

Health director-general Datuk Dr Noor Hisham Abdullah said this is because the drug had side effects and was also used to treat other illnesses. 

“One of the side effects is the cushing syndrome, thinning of the skin, and some series of side effects like bone loss and muscle weakness. 

“Depending on how long you use it, and (it will also cause) bone loss as well,” he said at the media briefing on the COVID-19 pandemic here today. 

Dr Noor Hisham said Dexamethasone was a type of steroid used to reduce inflammation for several illnesses, including cancer.  

“The Health Ministry takes cognisance of early developments in clinical trials for Dexamethasone in treating COVID-19, known as ‘Recovery Trial’ at the University of Oxford. 

“Early findings show that the drug can reduce fatality risks by one third among COVID-19 patients with serious respiratory symptoms, especially Category 5 patients who require ventilators. 

“However, the clinical trials also found that the drug was not effective in treating COVID-19 patients with mild symptoms or those who do not require breathing aid,” he said. 

He said Dexamethasone is only for use at the intensive care unit with a maximum dosage of four milligrammes for five days among Category 5 patients. 





BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires;; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.

Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter :, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial

© 2024 BERNAMA   • Disclaimer   • Privacy Policy   • Security Policy